Get the Stockscreener App
3.32
5.14%
-0.18
Shuttle Pharmaceuticals Holdings Inc stock is traded at $3.32, with a volume of 48,813.
It is down -5.14% in the last 24 hours and down -29.36% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.50
Open:
$3.461
24h Volume:
48,813
Relative Volume:
0.35
Market Cap:
$3.48M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-7.2174
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-2.92%
1M Performance:
-29.36%
6M Performance:
-81.02%
1Y Performance:
-93.65%
1-Day Range:
$3.2801
$3.49
1-Week Range:
$3.2801
$3.6799
52-Week Range:
$3.00
$82.50
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
3.32 | 3.75M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Applying Elliott Wave Theory to Shuttle Pharmaceuticals Holdings Inc.2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Smart tools for monitoring Shuttle Pharmaceuticals Holdings Inc.’s price actionEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-08-16 21:11:36 - Newser
What recovery options are there for Shuttle Pharmaceuticals Holdings Inc.2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Can volume confirm reversal in Shuttle Pharmaceuticals Holdings Inc.July 2025 Final Week & Verified Technical Signals - Newser
How to track smart money flows in Shuttle Pharmaceuticals Holdings Inc.Market Sentiment Summary & Daily Price Action Insights - Newser
What data driven models say about Shuttle Pharmaceuticals Holdings Inc.’s future - Newser
Tools to monitor Shuttle Pharmaceuticals Holdings Inc. recovery probabilityJuly 2025 Levels & Low Drawdown Momentum Ideas - Newser
Relative strength of Shuttle Pharmaceuticals Holdings Inc. in sector analysisGlobal Markets & Consistent Profit Trading Strategies - Newser
Regression analysis insights on Shuttle Pharmaceuticals Holdings Inc. performanceInsider Selling & AI Powered Trade Plan Recommendations - Newser
What analysts say about Shuttle Pharmaceuticals Holdings Inc. stock outlook2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Live market analysis of Shuttle Pharmaceuticals Holdings Inc.Gold Moves & Daily Profit Focused Stock Screening - Newser
Will Syndax Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsEarnings Risk Summary & Reliable Price Breakout Signals - Newser
Backtesting results for Shuttle Pharmaceuticals Holdings Inc. trading strategies2025 Top Gainers & Reliable Price Breakout Alerts - Newser
Published on: 2025-08-15 17:49:42 - Newser
Can you recover from losses in Shuttle Pharmaceuticals Holdings Inc.2025 Market Overview & Risk Managed Trade Strategies - Newser
Shuttle Pharma Provides Second Quarter 2025 Corporate Update - GlobeNewswire
Shuttle Pharma's Glioblastoma Treatment Shows Promise as Phase 2 Trial Advances with Strong Patient Tolerance - Stock Titan
Published on: 2025-08-14 00:17:15 - Newser
Is Shuttle Pharmaceuticals Holdings Inc. stock poised for growthAnalyst Downgrade & Free Long-Term Investment Growth Plans - Newser
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Shuttle Pharmaceuticals Holdings Inc. stock trendline breakdownEarnings Miss & Smart Money Movement Tracker - Newser
Shuttle Pharmaceuticals Holdings, Inc. SEC 10-Q Report - TradingView
Is Shuttle Pharmaceuticals Holdings Inc. reversing from oversold territoryEarnings Growth Summary & Entry Point Strategy Guides - Newser
Custom strategy builders for tracking Shuttle Pharmaceuticals Holdings Inc.Momentum Entry Alerts with Risk Control - Newser
Using data tools to time your Shuttle Pharmaceuticals Holdings Inc. exitBreakout Stock Opportunities with Low Drawdown - Newser
What Fibonacci levels say about Shuttle Pharmaceuticals Holdings Inc. reboundFree Daily Top Performing Stock Insights - Newser
Why Shuttle Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionTechnical Analysis of Growth Stock Opportunities - Newser
Should you wait for a breakout in Shuttle Pharmaceuticals Holdings Inc.Chart Driven Entry Timing for Swing Trades - Newser
Can a trend reversal in Shuttle Pharmaceuticals Holdings Inc. lead to recoveryMarket Stability and Long-Term Growth Outlook - Newser
Does Shuttle Pharmaceuticals Holdings Inc. qualify in momentum factor screeningFree Access to Smart Investment Tips - Newser
Published on: 2025-08-10 21:10:12 - Newser
Technical signs of recovery in Shuttle Pharmaceuticals Holdings Inc.Free Community Entry Consensus Trade Ideas - Newser
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.80%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):